Article info
Ovarian Cancer
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy
- Address correspondence and reprint requests to Parvin Tajik, MD, PhD, Department of Pathology, Academic Medical Centre – University of Amsterdam, Meibergdreef 9, 1100 DD, Amsterdam, the Netherlands Room M2-106; PO Box 22660. E-mail: P.Tajik{at}amc.uva.nl.
Citation
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy
Publication history
- Received June 30, 2017
- Accepted September 28, 2017
- First published March 1, 2018.
Online issue publication
March 01, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.